Albemarle (NYSE:ALB) Price Target Lowered to $65.00 at Scotiabank

Albemarle (NYSE:ALBGet Free Report) had its price objective decreased by analysts at Scotiabank from $75.00 to $65.00 in a research note issued on Tuesday,Benzinga reports. The brokerage currently has a “sector perform” rating on the specialty chemicals company’s stock. Scotiabank’s price objective indicates a potential upside of 12.36% from the stock’s previous close.

Other analysts also recently issued reports about the company. Evercore ISI downgraded Albemarle from an “outperform” rating to an “inline” rating in a report on Wednesday, February 5th. TD Securities cut their price objective on shares of Albemarle from $115.00 to $65.00 and set a “hold” rating on the stock in a report on Thursday, May 1st. StockNews.com raised shares of Albemarle to a “sell” rating in a research report on Monday. Morgan Stanley cut their price target on shares of Albemarle from $68.00 to $58.00 and set an “underweight” rating on the stock in a research note on Tuesday. Finally, BMO Capital Markets dropped their price objective on Albemarle from $150.00 to $140.00 in a report on Wednesday, February 12th. Three research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $92.43.

Read Our Latest Stock Analysis on ALB

Albemarle Stock Down 0.2 %

ALB traded down $0.09 during trading hours on Tuesday, hitting $57.85. 807,755 shares of the company’s stock were exchanged, compared to its average volume of 2,744,459. The company has a current ratio of 1.95, a quick ratio of 1.19 and a debt-to-equity ratio of 0.39. Albemarle has a 12-month low of $49.43 and a 12-month high of $137.50. The firm has a market cap of $6.81 billion, a P/E ratio of -5.16 and a beta of 1.71. The firm has a 50 day moving average of $66.01 and a 200 day moving average of $83.86.

Albemarle (NYSE:ALBGet Free Report) last announced its quarterly earnings data on Wednesday, April 30th. The specialty chemicals company reported ($0.18) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.62) by $0.44. Albemarle had a negative return on equity of 1.72% and a negative net margin of 21.93%. The business had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.18 billion. During the same quarter last year, the business posted $0.26 EPS. The business’s quarterly revenue was down 20.9% compared to the same quarter last year. Analysts predict that Albemarle will post -0.04 EPS for the current fiscal year.

Institutional Trading of Albemarle

A number of institutional investors have recently modified their holdings of the business. Manning & Napier Advisors LLC acquired a new stake in shares of Albemarle in the fourth quarter valued at about $85,570,000. Norges Bank purchased a new position in Albemarle in the fourth quarter valued at about $39,405,000. Vanguard Group Inc. lifted its position in shares of Albemarle by 2.5% during the 4th quarter. Vanguard Group Inc. now owns 14,594,499 shares of the specialty chemicals company’s stock valued at $1,256,294,000 after acquiring an additional 359,014 shares during the period. Pictet Asset Management Holding SA raised its holdings in shares of Albemarle by 36.7% during the 4th quarter. Pictet Asset Management Holding SA now owns 1,192,527 shares of the specialty chemicals company’s stock valued at $102,653,000 after buying an additional 320,150 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in Albemarle by 6,393.1% in the 1st quarter. GAMMA Investing LLC now owns 152,394 shares of the specialty chemicals company’s stock worth $10,975,000 after acquiring an additional 150,047 shares during the period. 92.87% of the stock is currently owned by hedge funds and other institutional investors.

About Albemarle

(Get Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

See Also

Analyst Recommendations for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.